ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132 | +34.7% | 6,361 | +54.2% | 0.00% | – |
| Q2 2023 | $98 | +71.9% | 4,125 | +35.8% | 0.00% | – |
| Q1 2023 | $57 | -99.9% | 3,037 | -17.7% | 0.00% | – |
| Q3 2022 | $60,000 | -16.7% | 3,689 | +18.4% | 0.00% | – |
| Q4 2021 | $72,000 | +67.4% | 3,115 | +19.4% | 0.00% | – |
| Q3 2021 | $43,000 | -40.3% | 2,609 | +92.4% | 0.00% | – |
| Q4 2020 | $72,000 | +30.9% | 1,356 | 0.0% | 0.00% | – |
| Q3 2020 | $55,000 | -67.8% | 1,356 | -66.6% | 0.00% | – |
| Q1 2020 | $171,000 | -93.5% | 4,060 | -93.4% | 0.00% | -100.0% |
| Q4 2019 | $2,645,000 | +9020.7% | 61,846 | +7488.5% | 0.00% | – |
| Q3 2019 | $29,000 | – | 815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |